Brion Umidi

Brion Umidi discloses dealings in Regen Biologics Inc to SEC (Form 4). In total, 3 filings cover trades dated from 30 November 2006 to 16 January 2009.

Purchases make up the whole of the open-market record (2 purchases, €12k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2009 to date brings 1 purchase and no sales.

Most recently, on 21 January 2009, the filings show an open-market purchase worth €8,890 in Regen Biologics Inc. The median gap between a trade and its publication by SEC (Form 4) is 5 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.